Sarcopenia as a prognostic factor for 90-day and overall mortality in patients undergoing spine surgery for metastatic tumors: a multicenter retrospective cohort study

HM Zakaria, BM Wilkinson, Z Pennington… - …, 2020 - journals.lww.com
BACKGROUND Novel methods in predicting survival in patients with spinal metastases may
help guide clinical decision-making and stratify treatments regarding surgery vs palliative …

[HTML][HTML] Omics-based molecular techniques in oral pathology centred cancer: prospect and challenges in Africa

HA Adeola, OO Soyele, AO Adefuye, SA Jimoh… - Cancer cell …, 2017 - Springer
Background The completion of the human genome project and the accomplished milestones
in the human proteome project; as well as the progress made so far in computational …

Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset

J Ho, X Li, L Zhang, Y Liang, W Hu, JCW Yau… - Seminars in Cancer …, 2019 - Elsevier
Malignancy of the pancreas is a leading cause of cancer-related mortality, with the highest
case-fatality of all cancers. Nevertheless, the lack of sensitive biomarkers and presence of …

Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: postnatal surge and organ-dependent regulation

YT Chen, L Trzoss, D Yang, B Yan - Toxicology, 2015 - Elsevier
Abstract Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two
major drug metabolizing enzymes that play critical roles in hydrolytic and oxidative …

[HTML][HTML] Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets

X Wang, C Guda - Medicine, 2016 - journals.lww.com
Background: Triple negative breast cancer (TNBC) is high-risk due to its rapid drug
resistance and recurrence, metastasis, and lack of targeted therapy. So far, no molecularly …

Noncovalent binding to DNA: still a target in developing anticancer agents

J Portugal, F Barcelo - Current Medicinal Chemistry, 2016 - ingentaconnect.com
DNA-binding compounds are of extraordinary importance in medicine, accounting for a
substantial portion of antitumor drugs in clinical usage. However, their mechanisms of action …

[PDF][PDF] The Interface of Cancer, Their Microenvironment and Nanotechnology.

N Roque, D Matias, J Balça-Silva… - … (Tech Science Press), 2022 - researchgate.net
Cancer is one of the deadliest diseases with a cure far from being found. Despite the
extraordinary advances in the therapy approaches, only a few patients respond to …

[HTML][HTML] Different perspectives on translational genomics in personalized medicine

B Doğan, HG Çelik, RD Küçükkaya… - Journal of the Turkish …, 2022 - ncbi.nlm.nih.gov
Personalized medicine is a relatively new and interesting concept in the medical and
healthcare industries. New approaches in current research have supported the search for …

[PDF][PDF] PUMP: An Underspecification Analysis Tool.

J Tang, MC Kressman, H Lakshmankumar… - …, 2023 - scitepress.org
In fields such as biomedicine, neural networks may encounter a problem known as
underspecification, in which models learn a solution that performs poorly and inconsistently …

[HTML][HTML] An overview of recommendations and translational milestones for genomic tests in cancer

CQ Chang, SR Tingle, KK Filipski, MJ Khoury… - Genetics in …, 2015 - nature.com
Purpose: To understand the translational trajectory of genomic tests in cancer screening,
diagnosis, prognosis, and treatment, we reviewed tests that have been assessed by …